Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to compare the effect on 24-hour blood glucose patterns,
HbA1c, and weight management when adding insulin glargine, or exenatide, or a combination of
insulin glargine and exenatide to metformin.
Phase:
N/A
Details
Lead Sponsor:
HealthPartners Institute
Collaborators:
International Diabetes Center at Park Nicollet Sanofi